[go: up one dir, main page]

AU2003287183A1 - Metal-containing materials, compositions and methods - Google Patents

Metal-containing materials, compositions and methods

Info

Publication number
AU2003287183A1
AU2003287183A1 AU2003287183A AU2003287183A AU2003287183A1 AU 2003287183 A1 AU2003287183 A1 AU 2003287183A1 AU 2003287183 A AU2003287183 A AU 2003287183A AU 2003287183 A AU2003287183 A AU 2003287183A AU 2003287183 A1 AU2003287183 A1 AU 2003287183A1
Authority
AU
Australia
Prior art keywords
compositions
methods
metal
containing materials
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003287183A
Other versions
AU2003287183A8 (en
Inventor
Robert E. Burrell
Kan Lam
Peter H. Moxham
Antony G. Naylor
Paul Schechter
John B. Wright
Hua Qing Yin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nucryst Pharmaceuticals Corp Canada
Original Assignee
Nucryst Pharmaceuticals Corp Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/277,298 external-priority patent/US6989157B2/en
Priority claimed from US10/277,673 external-priority patent/US20030180379A1/en
Priority claimed from US10/277,358 external-priority patent/US20030185901A1/en
Priority claimed from US10/277,362 external-priority patent/US20030194444A1/en
Priority claimed from US10/277,356 external-priority patent/US20030170314A1/en
Priority claimed from US10/277,320 external-priority patent/US20030206966A1/en
Application filed by Nucryst Pharmaceuticals Corp Canada filed Critical Nucryst Pharmaceuticals Corp Canada
Publication of AU2003287183A8 publication Critical patent/AU2003287183A8/en
Publication of AU2003287183A1 publication Critical patent/AU2003287183A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003287183A 2002-10-22 2003-10-22 Metal-containing materials, compositions and methods Abandoned AU2003287183A1 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US10/277,298 US6989157B2 (en) 2000-07-27 2002-10-22 Dry powders of metal-containing compounds
US10/277,673 US20030180379A1 (en) 2000-07-27 2002-10-22 Solutions and aerosols of metal-containing compounds
US10/277,362 2002-10-22
US10/277,320 2002-10-22
US10/277,673 2002-10-22
US10/277,358 US20030185901A1 (en) 2000-07-27 2002-10-22 Methods of treating conditions with a metal-containing material
US10/277,298 2002-10-22
US10/277,358 2002-10-22
US10/277,362 US20030194444A1 (en) 2000-07-27 2002-10-22 Methods of treating skin and integument conditions
US10/277,356 US20030170314A1 (en) 2000-07-27 2002-10-22 Compositions of metal-containing compounds
US10/277,356 2002-10-22
US10/277,320 US20030206966A1 (en) 2000-07-27 2002-10-22 Methods of inducing apoptosis and modulating metalloproteinases
US10/364,983 US7078060B2 (en) 2000-07-27 2003-02-12 Solutions and aerosols of metal-containing compounds
US10/364,983 2003-02-12
PCT/US2003/033446 WO2004037187A2 (en) 2002-10-22 2003-10-22 Metal-containing materials, compositions and methods

Publications (2)

Publication Number Publication Date
AU2003287183A8 AU2003287183A8 (en) 2004-05-13
AU2003287183A1 true AU2003287183A1 (en) 2004-05-13

Family

ID=32180857

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003287183A Abandoned AU2003287183A1 (en) 2002-10-22 2003-10-22 Metal-containing materials, compositions and methods

Country Status (4)

Country Link
EP (1) EP1575552A4 (en)
AU (1) AU2003287183A1 (en)
CA (1) CA2500836A1 (en)
WO (1) WO2004037187A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2678624C (en) 2003-05-16 2012-11-06 Exciton Technologies Inc. Deposition products, composite materials and processes for the production thereof
RU2306141C1 (en) * 2005-12-28 2007-09-20 Институт энергетических проблем химической физики Российской академии наук (ИНЭП ХФ РАН) Wound-healing accelerating agent
WO2009085651A1 (en) * 2007-12-20 2009-07-09 Nucryst Pharmaceuticals Corp. Metal carbonate particles for use in medicine and methods of making thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2200723A1 (en) * 1972-01-07 1973-07-19 Fresenius Chem Pharm Ind Ointment for treating epithelial skin damage,esp burns-contg - silver oxide and antibiotics
SU980695A1 (en) * 1981-03-13 1982-12-15 Московский научно-исследовательский институт туберкулеза Method of testing cavernous tuberculosis of the lungs
US5374432A (en) * 1989-07-28 1994-12-20 The Trustees Of Columbia University Of The City Of New York Topical anti-infective ointment containing silver or silver salts and antibiotics
US6258385B1 (en) * 1999-04-22 2001-07-10 Marantech Holding, Llc Tetrasilver tetroxide treatment for skin conditions
DE60210441T2 (en) * 2001-04-23 2006-11-16 Nucryst Pharmaceuticals Corp., Fort Saskatchewan MEDICAMENT OR PLASTER CONTAINS A METAL SUCH AS SILVER, GOLD, PLATINUM OR PALLADIUM AS AN ANTIMICROBIAL ACTIVE INGREDIENT AND ITS USE IN THE TREATMENT OF SKIN INFUSION

Also Published As

Publication number Publication date
EP1575552A4 (en) 2011-05-25
WO2004037187A2 (en) 2004-05-06
WO2004037187A8 (en) 2004-07-22
CA2500836A1 (en) 2004-05-06
WO2004037187A3 (en) 2004-09-02
AU2003287183A8 (en) 2004-05-13
EP1575552A2 (en) 2005-09-21

Similar Documents

Publication Publication Date Title
AU2003262747A1 (en) Compounds, compositions, and methods
AU2003236527A1 (en) Compounds, compositions, and methods
AU2003265242A1 (en) Compounds, compositions, and methods
AU2003270015A1 (en) Compounds, compositions, and methods
EP1503993A4 (en) Compounds, methods and compositions
AU2003299612A1 (en) Compounds, compositions and methods
EP1549269A4 (en) Cyclodextrin-based materials, compositions and uses related thereto
IL164581A0 (en) Compounds, compositions and methods
AU2003256805A1 (en) Compounds compositions and methods
AU2003277079A1 (en) Compounds, compositions, and methods
AU2003290507A1 (en) Compounds, compositions and methods
AU2003297079A1 (en) Anti-filming materials, compositions and methods
IL167936A0 (en) Compounds, compositions,and methods
AU2003267169A1 (en) Compounds, compositions and methods
AU2003300031A1 (en) Compounds, compositions, and methods
AU2003287183A1 (en) Metal-containing materials, compositions and methods
HK1074572A (en) Compounds, compositions, and methods
HK1074624A (en) Compounds, compositions, and methods
HK1074835A (en) Compounds, compositions, and methods
HK1074836A (en) Compounds, compositions, and methods
ZA200409130B (en) Compounds, compositions, and methods.
AU2003251425A1 (en) Mahoganoid polypeptides, and related compositions and methods
AU2002952442A0 (en) Probiotic Compositions, Combinations and Related Methods
AU2003906800A0 (en) Composition and Methods
AUPS081102A0 (en) Compositions and usestherefor-111

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase